Capricor Therapeutics logo
Capricor Therapeutics CAPR
$ 18.17 -3.96%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Capricor Therapeutics Deferred Revenue 2011-2024 | CAPR

Annual Deferred Revenue Capricor Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
24.3 M 18 M - - - - - 1.37 M 3.65 M 4.17 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
24.3 M 1.37 M 10.3 M

Quarterly Deferred Revenue Capricor Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
13.1 M 15.4 M 19.4 M 24.3 M 25.4 M 29.3 M 31 M 18 M 18.6 M 15.7 M 9.73 M - - - - - - - - - - - - - - - - - - - 684 K 1.37 M 1.37 M 1.37 M 1.37 M 3.65 M 3.65 M 3.65 M 3.65 M 4.17 M 4.17 M 4.17 M 4.17 M - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
31 M 684 K 10.7 M